As increased MDM2 expression suppresses GPRC5A, a tumor suppressor gene in A549 cells [39], our data might suggest that phenanthriplatin treatment could reduce MDM2 and thereby nullify the effect of GPRC5A to suppress tumor progression. Here, GPRC5A is linked to neoplasm.